Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Tiesrx
AddedFeb 18, 2024
UpdatedJun 18, 2026
Tiesrx

Tiesrx

Seed

TIESRx: A MedTech firm innovating cloud-based communication solutions for complex disease management.

HQ
Southlake, TX, US
Founded
2015
Overview
Compare
Fundraising
Employees

TIESRx, founded in 2015 and headquartered in Southlake, Texas, is a MedTech company dedicated to innovating communication solutions for individuals with complex diseases requiring ongoing and substantial care management. The company's core mission is to enhance patient care through advanced technology. TIESRx offers a customizable, cloud-based enterprise platform called TreatmentAdvantage™, designed to address industry-wide challenges in disease management by improving communication between patients, caregivers, and healthcare providers.

Notable affiliated people and investors include industry experts in healthcare technology and venture capitalists specializing in MedTech innovations. TIESRx has achieved significant milestones, including the successful deployment of TreatmentAdvantage™ in multiple healthcare settings, leading to improved patient outcomes and streamlined care processes. The company's impact is evident in its ability to bridge communication gaps in complex disease management, ultimately enhancing the quality of life for patients and efficiency for healthcare providers.

Tiesrx - Similar Companies

Twiage logo

Twiage

twiagemed.com

RxVantage logo

RxVantage

rxvantage.com

Caremesh logo

Caremesh

caremesh.com

Seremedi logo

Seremedi

seremedi.com

CrossTx logo

CrossTx

crosstx.com

RxLive logo

RxLive

rxlive.com

knowRX logo

knowRX

knowrxhealth.com

acesobee logo

acesobee

acesobee.com

Endotronix logo

Endotronix

endotronix.com

RxApps logo

RxApps

MedThread logo

MedThread

medthread.com

Care Thread logo

Care Thread

Trumed logo

Trumed

trumed.ai

Careier logo

Careier

careier.com

Clinnexus logo

Clinnexus

clinnexus.com

Tiesrx - Quick Facts

Who are Tiesrx's competitors?

Companies similar to Tiesrx include Twiage, RxVantage, Caremesh and Seremedi.

When was Tiesrx founded?

Tiesrx was founded in 2015.

Where is Tiesrx's headquarters located?

Tiesrx's headquarters is located in Southlake, TX, US.

When was Tiesrx's last funding round?

Tiesrx's most recent funding round was for $450k (USD) in August 2015.

How much has Tiesrx raised to-date?

As of Aug 5, 2015, Tiesrx has raised a total of $450k (USD).

How many employees does Tiesrx have?

Tiesrx has 5 employees as of Feb 5, 2024.

Tiesrx - Classification

Ownership
  • Private
  • Venture Capital
Technology
  • Cloud
Geographic Exposure
  • United States
Model
  • Platform
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Care Management
Tags
  • Healthtech
  • SaaS
NAICS
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
Show 7 more industry codes
NAICS
  • 513200Software Publishers
  • 510000Information
  • 513000Publishing Industries
  • 513210Software Publishers
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7372Prepackaged Software